Skip to main content
main-content

Cardiology

Cardiology

31-03-2019 | Oncology | News | Article

Abiraterone may raise mortality risk in men with prostate cancer, CVD

Among men initiating abiraterone acetate for advanced prostate cancer, the mortality risk may be higher for those with versus without pre-existing cardiovascular disease, suggests a real-world study presented at the AACR Annual Meeting 2019 in Atlanta, Georgia, USA.

27-03-2019 | Cardiovascular | News | Article

Cardiovascular autonomic neuropathy can be reversed in type 2 diabetes

Cardiovascular autonomic neuropathy is reversible in people with type 2 diabetes, report Korean researchers who found that age was the most important predictor of recovery.

22-03-2019 | Cardiovascular | News | Article

HIIT plus resistance training may have cardiovascular benefits in type 2 diabetes

A 1-year exercise intervention combining high-intensity interval training with resistance training may improve measures of cardiovascular risk among people with type 2 diabetes, suggests a secondary analysis of the D2FIT trial.

12-10-2018 | Breast cancer | News | Article

Endocrine therapy impacts cardiovascular risk in women with breast cancer

Long-term use of adjuvant endocrine therapy by women with a history of nonmetastatic breast cancer can significantly alter their risk for some types of cardiovascular disease, a meta-analysis shows.

11-10-2018 | Neurology | News | Article

Anticoagulants could stave off increased risk of dementia associated with AF

Study findings show an increased risk of dementia in older people with atrial fibrillation and support the use of anticoagulants to reduce the likelihood.

13-03-2018 | Oncology | News | Article

Data further highlight link between childhood cancer and long-term CVD risk

Young adult survivors of childhood cancer are at increased risk for cardiovascular disease, which develops earlier than in the general population, German study findings confirm.

02-01-2018 | Oncology | News | Article

Cardiovascular toxicity common with carfilzomib for multiple myeloma

Carfilzomib is associated with a high rate of clinically significant cardiovascular adverse events in patients with multiple myeloma, show results of a systematic review and meta-analysis.

11-12-2017 | Rheumatology | News | Article

High coronary plaque burden in PsA patients

Psoriatic arthritis is associated with accelerated coronary plaque formation independently of metabolic disease, according to results from a single-center study.

18-09-2017 | Rheumatology | News | Article

RA disease activity and severity play ‘important role’ in reducing CVD risk

Targeting factors such as inflammation and disease activity in patients with rheumatoid arthritis could help reduce their risk for cardiovascular disease, study findings suggest.

30-08-2017 | Rheumatology | News | Article

Ibuprofen associated with elevated blood pressure in patients with arthritis

Patients with osteoarthritis or rheumatoid arthritis who take ibuprofen are more likely to experience an increase in systolic blood pressure than those taking celecoxib, results of the PRECISION-ABPM study suggest.

28-07-2017 | Oncology | News | Article

Statin eligibility points to increased cancer risk

Individuals eligible for statins according to the 2013 American College of Cardiology/American Heart Association guidelines have a significantly increased risk for developing or dying of cancer compared with noneligible individuals, US researchers report.

30-06-2017 | Rheumatology | News | Article

Low disease activity reduces RA-associated CVD risk

Low disease activity could delay the time to first cardiovascular disease event in patients with rheumatoid arthritis.

19-04-2017 | Rheumatology | News | Article

Celecoxib linked to reduced GI bleeding risk in patients with arthritis, cardiothrombotic disease

Results of the CONCERN trial suggest that celecoxib is associated with a lower risk for recurrent upper gastrointestinal bleeding than naproxen among patients with arthritis and cardiothrombotic diseases treated concomitantly with aspirin and non-steroidal anti-inflammatory drugs.

07-03-2017 | Public health | Highlight | Article

Diet associated with ‘substantial proportion’ of cardiometabolic deaths

Research published in JAMA suggests that suboptimal intake of specific dietary factors is associated with almost half of deaths from heart disease, stroke, or type 2 diabetes in the USA.

06-03-2017 | Pulmonary hypertension | News | Article

Systemic sclerosis associated with poor survival in CTD-PAH

A Chinese cohort study identifies factors associated with prognosis among patients with connective tissue disease-associated pulmonary arterial hypertension.

03-03-2017 | Interventional cardiology | News | Article

No benefit of ischemic postconditioning during PCI

Results of the DANAMI-3–iPOST trial suggest that ischemic postconditioning during percutaneous coronary intervention does not improve clinical outcome for patients with ST-segment elevation myocardial infarction.

03-03-2017 | Pulmonary hypertension | News | Article

Right atrial strain associated with clinical outcomes in PAH

Study results suggest that right atrial strain could predict adverse outcomes among patients with pulmonary arterial hypertension.

02-03-2017 | Interventional cardiology | News | Article

Benefits of complete versus target-only revascularization examined in multivessel CAD

Results of a meta-analysis suggest that complete revascularization is associated with a reduced risk for cardiac events, but not overall mortality, among patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.

01-03-2017 | Arrhythmia | News | Article

No reduction in AF recurrence with aggressive blood pressure treatment

Reducing target blood pressure does not decrease the incidence of recurrent arrhythmia among patients undergoing catheter ablation for atrial fibrillation, results of a randomized trial suggest.

24-02-2017 | Cardiology | News | Article

No reduction in intraoperative bleeding with fibrinogen concentrate

Results of a randomized trial published in JAMA suggest that infusion of fibrinogen concentrate does not reduce intraoperative blood loss during high-risk cardiac surgery.

image credits